Biological and clinical implications of cancer stem cells in primary brain tumors
Despite therapeutic advances, glioblastoma multiforme (GBM) remains a lethal disease. The infiltrative nature of this disease and the presence of a cellular population resistant to current medical treatments account for the poor prognosis of these patients. Growing evidence indicates the existence o...
Main Authors: | Marcello eMaugeri-Saccà, Simona edi Martino, Ruggero eDe Maria |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00006/full |
Similar Items
-
Therapeutic targeting of cancer stem cells
by: Marcello eMaugeri-Saccà, et al.
Published: (2011-06-01) -
Dual Specificity Kinase DYRK3 Promotes Aggressiveness of Glioblastoma by Altering Mitochondrial Morphology and Function
by: Kyeongmin Kim, et al.
Published: (2021-03-01) -
Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
by: Shang-Yu Chou, et al.
Published: (2018-01-01) -
PACAP and VIP inhibit the invasiveness of glioblastoma cells exposed to hypoxia through the regulation of HIFs and EGFR expression
by: Grazia eMaugeri, et al.
Published: (2016-05-01) -
Brain Cancer Stem Cells: Current Status on Glioblastoma Multiforme
by: Gilbert Bernier, et al.
Published: (2011-03-01)